scispace - formally typeset
E

Eric Chan

Researcher at Vertex Pharmaceuticals

Publications -  8
Citations -  388

Eric Chan is an academic researcher from Vertex Pharmaceuticals. The author has contributed to research in topics: Immunotoxin & Fusion protein. The author has an hindex of 5, co-authored 8 publications receiving 336 citations.

Papers
More filters
Journal ArticleDOI

Novel Cell- and Tissue-Based Assays for Detecting Misfolded and Aggregated Protein Accumulation Within Aggresomes and Inclusion Bodies

TL;DR: A homogenous fluorescence-based assay was devised to detect aggregated proteins inside aggresomes and inclusion bodies within an authentic cellular context, allowing assessment of the effects of protein aggregation directly in cells, without resorting to the use of non-physiological protein mutations or genetically engineered cell lines.
Journal ArticleDOI

A novel image-based cytometry method for autophagy detection in living cells

TL;DR: A novel method using the Cellometer image-based cytometry/fluorescent dye method in combination with Cyto-ID® Green dye for autophagy detection in live cells is developed and compared with flow cytometry by measuring macroautophagy in nutrient-starved Jurkat cells.
Proceedings ArticleDOI

Abstract 5346: A novel immunotoxin comprising quadruple RNase tethered to an internalizing anti-TROP-2 humanized MAb shows potent cytotoxicity against diverse solid tumorsin vitro

TL;DR: The cell binding data obtained for these solid cancer cell lines suggest that the sensitivity of a cell line to E1-Rap appears to correlate with its TROP-2 expression on the cell surface, which is 1,000- to 100,00-fold higher than untargeted Rap or the combination of Rap and hRS7.